Remember to size for success with #ShockwaveIVL#. Watch a case where Dr. Paul Foley treats calcified bilateral CIA stenoses with 12.0 mm #ShockwaveL6# for an outstanding result. See what the Large and In Charge Shockwave L6 can do for your cases: US Rx only. Safety Info:  availability may vary by country.

Shockwave E8 and Shockwave L6: successful cases in Greece and Cyprus Four hospitals. Four successful cases. One shared goal: advancing calcium treatment. We are proud to share the use of Shockwave E8 and Shockwave L6 across four leading institutions: 1. Areteeion Hospital in Cyprus with Dr. Charalambous 2. Hygeia Hospital in Athens with Dr. Kalliafas 3. University Hospital of Rio - Patras with Prof. Karnabatidis and Prof. Katsanos 4. Laiko university hospital of Athens with Dr. Gremoutis These cases represent a strong launching pad for further advancing calcium treatment in Greece and Cyprus. A big thank you to SOFMEDICA for the collaboration! #ShockwaveE8# #ShockwaveL6# #CalciumTreatment# #ShockwaveIVL# US Rx only. Safety Info:  Product availability may vary by country.

Shockwave IVL and innovation continue to go hand in hand as we deliver new advancements to address severe, complex calcium meeting physician and patient needs alike. Thank you, Dr. @rwyeh for presenting the FORWARD CAD 30-day results at #TCT2026# today. FORWARD CAD met its performance goals, demonstrating high technical success (93.6%) and a high rate of freedom from MACE through 30 days (93.4%) in a highly stenotic lesion cohort. These data from the prospective, multicenter, single-arm, IDE study of the Shockwave Javelin #CoronaryIVL# catheter show how the robust #ShockwaveIVL# portfolio is expanding beyond balloon-based therapies for the coronaries. Read the press release: CAUTION - Investigational device. Limited by US law to investigational use.

#ShockwaveC2AeroFly# has taken flight across America. Next stop: #TCT2026# ✈️ Congratulations to the physicians and cath lab teams behind the first commercial cases, experiencing the benefits of 2x-faster pulsing firsthand. Join us at TCT as #ShockwaveCoronaryIVL# continues to lead the conversation around the treatment of complex coronary calcification. Attend the Training Pavilion sessions or visit our booth to experience our next-generation #CoronaryIVL# catheter firsthand. ⚡ Explore all we're bringing to TCT:  Drs. Ziad Ali (@ziadalinyc), Rich Shlofmitz, Evan Shlofmitz (@ESHLOF), Paul Sapia (@PaulSap9), Allen Jeremias (@DrAllenJ), Annapoorna Kini (@DoctorKini), Samin Sharma, Amit Hooda (@AmithoodaMD), Prashant Kaul (@KaulP), Hector Tamez (@hectortamezmd), Robert Stoler, Subhash Banerjee, Chadi Dib, Karim Al-Azizi (@kalazizimd), Emmanouil Brilakis (@esbrilakis), and Yousif Ahmad US Rx only. Safety Info: Product availability may vary by country.

#ShockwaveC2AeroFly# is set for takeoff. ⚡✈️ Don't miss Drs. Yousif Ahmad, Ziad Ali (@ziadalinyc), Emmanouil Brilakis (@esbrilakis), and Rhian Davies (@RhianEDavies1) at #TCT2026# as they discuss complex coronary calcium, the critical clinical evidence behind the Shockwave IVL portfolio, and the next era of treatment with Shockwave C2 Aero Fly. 📅 Monday, November 2 | 12:45–1:45 PM Meet us as @JNJMedTech circulatory restoration solutions for the first time and see what's on board for #TCT#:  @TCTConference #ShockwaveIVL# #JNJMedTech# Presenting physicians are paid consultants of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

#ShockwaveIVL’s# clinical evidence is different. Our predictably safe and consistently effective MOA has been validated by nearly 25,000 published patient outcomes across more than 600 scientific publications. To date, we have supported more than 70 company-led and investigator-initiated clinical studies, with an additional 50 planned between 2025 and 2029. Each study is designed to reflect the complex scenarios physicians encounter every day and to generate the clinical evidence needed to support confident adoption of Shockwave IVL. Read this new Cardiac Interventions Today article by our CMO, Nick West, to learn what our relentless commitment to research means for the future of calcium modification:  US Rx only. Safety Info:  availability may vary by country.

#ShockwaveC2Aero# continues to make waves across Northern UK and Ireland! With improved deliverability and a fast procedural flow, Shockwave C2 Aero is designed to reach and treat even the most challenging calcified coronary lesions. These first cases mark more than a launch milestone. They reflect #ShockwaveIVL’s# commitment to innovation and serve as a powerful reminder of what innovation is truly for, making complex care more achievable, consistent, and patient centered. We're proud to stand alongside UK and Irish interventional cardiologists in tackling complex coronary calcium. US Rx only. Safety Info: ​ Product availability may vary by country.

Take #ShockwaveC2AeroFly# for a test flight at #TCT2026#. ⚡✈️ Join the PCI Skills Pavilion and hear from Drs. James Spratt (@jcspratt), Leah Raj, Thuy Ryan (@ThuyPhamDO), Carlos Collet (@ColletCarlos), Salman Arain (@DrSalmanArain), and Dhananjay Chatterjee (@dchatterjee824) as they discuss how angiography, CCTA, and intravascular imaging can help identify and assess calcium, followed by hands-on experience with #ShockwaveC2AeroFly#. 📅 Monday, November 2 | 2:00-3:30 PM and 4:00-5:30 PM Build your TCT flight plan and join our circulatory restoration solutions Training Pavilion:  @TCTConference #ShockwaveIVL# #JNJMedTech# Presenting physicians are paid consultants of Johnson & Johnson. US Rx only. Safety Info: Product availability may vary by country.

Meet #ShockwaveC2AeroFly#, the next-generation #CoronaryIVL# catheter designed to treat calcified coronary disease more efficiently. What makes it different? Faster pulsing, shorter pause time, reduced patient ischemic time, and leading deliverability, crossability and repositioning capabilities of the #ShockwaveC2Aero# platform come together to enable physicians to treat calcified CAD faster through patient-focused innovation. Learn more on our website:  Read the Press Release: US Rx only. Safety Info:  availability may vary by country.